Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.
about
A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population.Achieving therapeutic vancomycin levels in pediatric patientsDose regimen for vancomycin not needing serum peak levels?Clinical pharmacokinetics of vancomycin in the neonate: a reviewAn investigation into the vancomycin concentration in the cerebrospinal fluid due to vancomycin intraventricular administration in newborns: a study of 13 casesCorrelation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database reviewImpact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.Considerations in the pharmacologic treatment and prevention of neonatal sepsis.Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.A Systematic Review of Vancomycin Dosing and Monitoring in Burn Patients.Vancomycin Dosing and Pharmacokinetics in Postoperative Pediatric Cardiothoracic Surgery Patients.Assessment of initial vancomycin dosing in neonatesVancomycin AUC/MIC and Corresponding Troughs in a Pediatric Population.Vancomycin and gentamicin pharmacokinetic alterations in an adolescent amputee.Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.Pharmacokinetic Characteristics and Clinical Outcomes of Vancomycin in Young Children With Various Degrees of Renal Function.Pharmacokinetics and dose requirements of vancomycin in neonates.Monitoring the treatment of sepsis with vancomycin in term newborn infants.The kinetic profile of vancomycin in neonates.What do I need to know about glycopeptide antibiotics?
P2860
Q33978650-E5F5954D-645F-4FDE-9D6B-16A5C7DF6096Q34764337-F766EF63-B538-4C22-9DA6-37B6FC29F1A7Q35292492-81BF1976-CD8F-4FE0-B5C4-DD2297343300Q36104107-3030F4CA-7F33-470B-9181-B628DB6E9D02Q36193692-BEA23506-5E9E-47F3-99DB-FD5654C3E9C4Q36290499-539876AB-6668-442B-9398-3ADEEAFD110AQ37055102-9E15AC2B-81C0-4C70-83F9-E12F06C7F809Q37712974-0E742F35-7514-4C9D-BD2B-97DD502D01A4Q38161849-BED306D2-7AD6-4F0E-A4B1-F34CD99A1B4CQ38215682-72B3A785-ACF4-411F-8C8D-9DD3EA2672BAQ38258649-9AB30DBF-3E7D-4AB5-9E0E-398BF904B104Q38271273-B58243D2-F19B-4335-92CC-A592E1224F54Q38784479-6AB9612F-25F9-423E-B527-FEA084167BCEQ39110114-AAD8A41E-A967-40B3-91BF-32CCC953361EQ39197603-B8E3061B-9A9A-4F96-8AA0-28A35A664DABQ39839904-355D9FB3-3D23-4575-8D28-53E021B7BD29Q40749709-8B5E4149-CA0E-46E2-8028-695BA0A3CD84Q40964689-F0637E1E-C609-4B14-B4CB-18295FCAB438Q43097632-53B5F214-5158-4019-A958-D0B57DBC1AD3Q43621778-3CC102A1-1D3C-4DF7-A7ED-FA14DD68E675Q52180861-6E07D822-0E5D-4F69-9D71-16BA2D95520CQ54559172-83C6640A-696E-40B7-A0E5-737B84CCC4F3
P2860
Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Pharmacokinetics and administr ...... eonates, infants and children.
@en
type
label
Pharmacokinetics and administr ...... eonates, infants and children.
@en
prefLabel
Pharmacokinetics and administr ...... eonates, infants and children.
@en
P2093
P1476
Pharmacokinetics and administr ...... eonates, infants and children.
@en
P2093
P356
10.2165/00003088-199733010-00004
P577
1997-07-01T00:00:00Z
P6179
1008943203